Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
27.16
+0.48 (1.80%)
Sep 16, 2026, 3:00 PM EDT - Market open
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $4.33 billion as of September 16, 2026. Its market cap has increased by 117.63% in one year.
Market Cap
4.33B
Enterprise Value
4.37B
1-Year Change
117.63%
Ranking
Category
Stock Price
$27.16
ChartMarket Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $4.33B, a decrease of -9.21%. That is a compound annual growth rate of -1.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 4.33B | 74.83% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qiagen | 8.96B |
| RadNet | 6.08B |
| Sotera Health Company | 5.58B |
| BillionToOne | 4.97B |
| GRAIL | 3.45B |
| Veracyte | 3.20B |
| GeneDx Holdings | 2.94B |
| CareDx | 2.79B |